Daniel J. Becker
CIK 1752139 · last filed 2025-05-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
21
Lifetime Open-Market Net
$40.41M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZURA | Director | — | $3.70 | — | $0 | 1 | 2025-05-29 |
| ACELYRIN, Inc. (SLRN) Delisted | Director | 2,999 | $2.27 | $6.8K | $54.0K | 3 | 2024-07-19 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | 5,000 | $21.53 | $107.7K | $80.0K | 3 | 2023-06-26 |
| Pandion Therapeutics, Inc. (PAND) Delisted | Director | 0 | $60.05 | $0 | $16.46M | 4 | 2021-04-01 |
| Principia Biopharma Inc. (PRNB) Delisted | Director | 0 | — | — | $23.81M | 8 | 2020-09-28 |
Recent Filings · Page 3 of 3
21 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-09-20 | Principia Biopharma Inc. (PRNB) Delisted | Mixed | +2,625,713 | $4.59M | EDGAR |
Showing 21–21 of 21
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.